"Hôpital public à Lille"

During the past decade, Hopital Calmette conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 15 clinical trials were completed, i.e. on average, 31.9% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Calmette" #1 sponsor was "University Hospital, Lille" with 20 trials, followed by "Boehringer Ingelheim" with 9 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 8 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Calmette" #1 collaborator was "Roche Pharma AG" with 4 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "Institut Pasteur de Lille" with 2 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator and "Santelys Association" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Calmette" are "Cystic Fibrosis" (8 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Lung Cancer" (4 trials) and "Asthma" (3 trials). Many other conditions were trialed in "Hopital Calmette" in a lesser frequency.

Most popular intervention types in "Hopital Calmette" are "Drug" (42 trials), "Other" (9 trials), "Device" (4 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Nintedanib" (6 trials), "Pemetrexed" (5 trials), "Carboplatin" (3 trials) and "ELX/TEZ/IVA" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Calmette" are 68 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Calmette". undefined are not yet recruiting, 18 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Hopital Calmette, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Calmette, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 9 trials that are defined as “Not Applicable".